Expansion of granulocyte colony-stimulating factor/chemotherapy- mobilized CD34+ hematopoietic progenitors: Role of granulocyte-macrophage colony-stimulating factor/erythropoietin hybrid protein (MEN 11303) and interleukin-15

Experimental Hematology

Volumn 27, Issue 3, 1999, Pages 416-424

  Pierelli, Luca ^a   Scambia, Giovanni ^a   Bonanno, Giuseppina ^a   Coscarella, Annamaria ^b   De Santis, Rita ^b   Mele, Antonio ^b   Battaglia, Alessandra ^a   Fattorossi, Andrea ^a   Romeo, Virgilio ^a   Menichella, Giacomo ^a   Mancuso, Salvatore ^a   Leone, Giuseppe ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b Menarini Ricerche SpA   (Italy)

Author keywords

Circulating CD34+ cells; Flt3 ligand; Granulocyte macrophage colony stimulating factor erythropoietin hybrid protein; Interleukin 15; Peg rHuMGDF; Progenitor expansion

Indexed keywords

CD4 ANTIGEN; ERYTHROPOIETIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYBRID PROTEIN; INTERLEUKIN 15;

ARTICLE; BURST FORMING UNIT E; CELL SPECIFICITY; COLONY FORMING UNIT GM; ERYTHROPOIESIS; GROWTH REGULATION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CELLS, CULTURED; COLONY-FORMING UNITS ASSAY; ERYTHROPOIESIS; ERYTHROPOIETIN; FEMALE; FMS-LIKE TYROSINE KINASE 3; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; HUMANS; INTERLEUKIN-15; MIDDLE AGED; OVARIAN NEOPLASMS; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES;

EID: 0032979030     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(98)00056-3     Document Type: Article

References (48)

1. Kessinger A., Armitage J.O. The evolving role of autologous peripheral stem cell transplantation following high-dose therapy for malignancies. Blood. 77:1991;211.
2. Korbling M., Champlin R. Peripheral blood progenitor cell transplantation. a replacement for marrow auto- or allografts Stem Cells. 14:1996;185.
3. Brugger W., Heimfeld S., Berenson R.J., Mertelsmann R., Kanz L. Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo. N Engl J Med. 333:1995;283.
4. + cells in autologous stem cell transplantation for breast cancer. Blood. 87:1996;1687.
5. Alcorn M.J., Holyoake T.L., Richmond L., Pearson C., Farrell E., Kyle B., Dunlop D.J., Fitzsimons E., Steward W.P., Pragnell I.B., Franklin I.M. CD34-positive cells isolated from cryopreserved peripheral-blood progenitor cells can be expanded ex vivo and used for transplantation with little or no toxicity. J Clin Oncol. 14:1996;1839.
6. + cells into the myeloid lineage. Blood. 80:1992;1405.
7. + progenitor cells by stem cell factor, interleukin-1β (IL-1β), IL-6, IL-3, Interferon-γ, and erythropoietin. Blood. 81:1993;2579.
8. +-selected human peripheral blood progenitor cells. Blood. 84:1994;2898.
9. Eaves C.J., Sutherland H.J., Udomsakdi C., Lansdorp P.M., Szilvassy S.J., Fraser C.C., Humphries R.K., Barnett M.J., Phillips G.L., Eaves A.C. The human hematopoietic stem cell in vitro and in vivo. Blood Cells. 18:1992;301.
10. Moore M.A.S. Clinical implications of positive and negative hematopoietic stem cells regulators. Blood. 78:1991;1.
11. - cells cultured with interleukin-3, granulocyte colony-stimulating factor, or granulocyte-macrophage colony-stimulating factor. Blood. 77:1991;2316.
12. McNiece I.K., Langley K.E., Zsebo K.M. Recombinant human stem cell factor synergises with GM-CSF, G-CSF, IL-3 and EPO to stimulate human progenitor cells of the myeloid and erythroid lineages. Exp Hematol. 19:1991;226.
13. Gabbianelli M., Pelosi E., Montesoro E., Valtieri M., Luchetti L., Samoggia P., Vitelli L., Barberi T., Testa U., Lyman S., Peschle C. Multi-level effects of flt3 ligand on human hematopoiesis. expansion of putative stem cells and proliferation of granulomonocytic progenitors/monocytic precursors Blood. 86:1995;1661.
14. + bone marrow progenitor cells in vitro. Blood. 87:1996;1317.
15. - cells and maintains progenitor cells in vitro. Blood. 87:1996;3536.
16. Koller M.R., Oxender M., Brott D.A., Palsson B.O. Flt-3 ligand is more potent than c-kit ligand for the synergistic stimulation of ex vivo hematopoietic cell expansion. J Hematother. 5:1996;449.
17. -) human bone marrow progenitor cells. Distinct and key interactions with the ligands for c-kit and flt3, and inhibitory effects of TGF-β and TNF-α J Immunol. 158:1997;5169.
18. Piacibello W., Sanavio F., Garetto L., Severino A., Bergandi D., Ferrario J., Fagioli F., Berger M., Aglietta M. Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood. Blood. 89:1997;2644.
19. Coscarella A., Carloni C., Liddi R., Mauro S., Novelli S., Mele A., Masella B., Valtieri M., De Santis R. Production of recombinant human GM-CSF-EPO hybrid proteins. in vitro biological characterization Eur J Haematol. 59:1997;238.
20. + hematopoietic progenitor cells. Blood. 87:1996;2632.
21. Koller M., Emerson S.G., Palsson B.O. Large-scale expansion of human stem and progenitor cells from bone marrow mononuclear cells in continuous perfusion cultures. Blood. 82:1993;378.
22. Pierelli L., Menichella G., Paoloni A., Vittori M., Foddai M.L., Serafini R., Rumi C., Mitschulat H., Rossi P.L., Scambia G., Teofili L., Sica S.et al. Evaluation of a novel automated protocol for the collection of peripheral blood stem cells mobilized with chemotherapy or chemotherapy plus G-CSF using the AS104 Fresenius cell separator. J Hematother. 2:1993;145.
23. Menichella G., Pierelli L., Scambia G., Salerno G., Benedetti Panici P., Foddai M.L., Serafini R., Vittori M., Lai M., Ciarli M., Mancuso S., Bizzi B. Low-dose cyclophosphamide in combination with cisplatin or epirubicin plus rhG-CSF allows adequate collection of PBSC for autotransplantation during adjuvant therapy for high-risk cancer. Bone Marrow Transplant. 14:1994;907.
24. + progenitors undergo selective erythroid differentiation in liquid culture in the presence of erythropoietin and stem cell factor. Br J Haematol. 96:1997;55.
25. Sutherland H.J., Lansdorp P.M., Henkelman D.H., Eaves A.C., Eaves C.J. Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow stromal layers. Proc Natl Acad Sci U S A. 87:1990;3584.
26. Sutherland H.J., Eaves C.J., Lansdorp P.M., Thacker J.D., Hogge D.E. Differential regulation of primitive hematopoietic cells in long-term cultures maintained on genetically engineered murine stromal cells. Blood. 78:1991;666.
27. de St Groth S.F. The evaluation of limiting dilution assays. J Immunol Methods. 49:1982;R11.
28. Finney D.J. The estimation of bacterial densities from dilution series. J Hygiene. 49:1951;26.
29. + cell selection and perfusion on ex vivo expansion of peripheral blood mononuclear cells. Blood. 86:1995;958.
30. Palsson B.O., Oh D.J., Koller M.R. Replating of bioreactor expanded human bone marrow results in extended growth of primitive and mature cells. Cytotechnology. 18:1995;125.
31. Champlin R., Mehra R., Gaiewsky J., Khouri I., Geisler D., Davis M., Oba K., Thomas M., Armstrong R.D., Douville J., Weber S., Silver S.et al. Ex vivo expanded progenitor cell transplantation in patients with breast cancer. Blood. 86(suppl. 1):1995;295a.
32. + haematopoietic progenitor cells. Br J Haematol. 99:1997;951.
33. + blood cells in multiple myeloma. Br J Haematol. 96:1997;403.
34. Holyoake T.L., Alcorn M.J., Richmond L., Pearson C., Farrell E., Kyle B., Dunlop D.J., Fitzsimons E., Steward W.P., Pragnell I.B., Franklin I.M. A phase I study to evaluate the safety of re-infusing CD34 cells expanded ex vivo as part or all of a PBPC transplant procedure. Blood. 86(suppl. 1):1995;294a.
35. + cells selected from leukapheresis products of lymphoma and myeloma patients. feasibility and enhancement by fibronectin J Hematother. 5:1996;671.
36. Curtis B.M., Williams D.E., Broxmeyer H.E., Dunn J., Farrah T., Jeffrey E., Clevenger W., deRoos P., Martin U., Friend D., Craig V., Gayle R.et al. Enhanced hematopoietic activity of a human granulocyte/macrophage colony-stimulating factor-interleukin 3 fusion protein. Proc Natl Acad Sci U S A. 88:1991;5809.
37. Lu L., Xiao M., Li Z.-H., Joliffe L.K., Jones S., Broxmeyer H.E., Weich N. Influence of IL-3/Epo fusion proteins compared with the combination of IL-3 plus Epo in enhancing the proliferation of single isolated erythroid and multipotential progenitor cells from human umblical cord blood and adult bone marrow. Exp Hematol. 23:1995;1130.
38. Testa U., Fossati C., Samoggia P., Masciulli R., Mariani G., Hassan H.J., Sposi N.M., Guerriero R., Rosato V., Gabbianelli M., Pelosi E., Valtieri M.et al. Expression of growth factor receptors in unilineage differentiation culture of purified hematopoietic progenitors. Blood. 88:1996;3391.
39. Ihle J.N. Cytokine receptor signaling. Nature. 377:1995;591.
40. Youssoufian H., Longmore G., Neumann D., Yoshimura A., Lodish H.F. Structure, function, and activation of the erythropoietin receptor. Blood. 81:1993;2223.
41. - cell production in vitro. Br J Haematol. 98:1997;528.
42. Adelmann M., Schulze D., Osten C.V., Pfefferkon L., Beyer C., Emmerich B., Straka C. Ex vivo blood stem cell expansion in liquid culture with cytokine cocktails. a role for thrombopoietin Blood. 88(suppl. 1):1996;604a.
43. Sonoda Y., Ohmizono y Kimura T., Sakabe H., Tanimukai S., Lyman S.D., Abe T. Thrombopoietin augments ex vivo expansion of human cord blood derived hematopoietic progenitors in combination with stem cell factor and FLT3 ligand. Blood. 88(suppl. 1):1996;602a.
44. Grabstein K.H., Eisenman J., Shanebeck K., Rauch C., Srinivasan S., Fung V., Beers C., Richardson J., Schoenborn M.A., Ahdieh M., Johnson L., Alderson M.R.et al. Cloning of a T cell growth factor that interacts with the β chain of the interleukin-2 receptor. Science. 264:1994;965.
45. Carson W.E., Giri J.G., Lindemann M.J., Linett M.L., Ahdieh M., Paxton R., Anderson D., Eisenman J., Grabstein K., Caligiuri M.A. Interleukin (IL)15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J Exp Med. 180:1994;1395.
46. Giri J.G., Ahdieh M., Eisenman J., Shanebeck K., Grabstein K., Kumaki S., Namen A., Park L.S., Cosman D., Anderson D. Utilization of the β and γ chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J. 13:1994;2822.
47. - bone marrow progenitors. J Immunol. 150:1993;5263.
48. + NK progenitor Blood. 83:1994;2594.